TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle

Journal of Applied Physiology

Volumn 114, Issue 11, 2013, Pages 1629-1636

  Stasko, Shawn A ^a   Hardin, Brian J ^a   Smith, Jeffrey D ^a   Moylan, Jennifer S ^a   Reid, Michael B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cytokines; Diaphragm; Inflammation; Oxidative stress; Weakness

Indexed keywords

CYTOKINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS1 PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DIAPHRAGM; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; MUSCLE STRENGTH; OXIDATIVE STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION; WEAKNESS;

CYTOKINES; DIAPHRAGM; INFLAMMATION; OXIDATIVE STRESS; WEAKNESS;

ANIMALS; CELLS, CULTURED; DIAPHRAGM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE STRENGTH; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878610390     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00871.2012     Document Type: Article

References (67)

1. Alloatti G, Penna C, Mariano F, Camussi G. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol Regul Integr Comp Physiol 279:R2156-R2163, 2000.
2. Andrade FH, Reid MB, Allen DG, Westerblad H. Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J Physiol 509:565-575, 1998. (Pubitemid 28287013)
3. Andrade FH, Reid MB, Allen DG, Westerblad H. Effect of nitric oxide on single skeletal muscle fibres from the mouse. J Physiol 509:577-586, 1998. (Pubitemid 28287014)
4. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, Gea J, Barbera JA. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182:477-488, 2010.
5. Beckham JC, Caldwell DS, Peterson BL, Pippen AM, Currie MS, Keefe FJ, Weinberg JB. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. J Clin Immunol 12:353-361, 1992.
6. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A. Tumor necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 5:e13262, 2010.
7. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84:757-767, 1996. (Pubitemid 26094205)
8. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15:1753-1765, 1996. (Pubitemid 26119211)
9. Cicoira M, Bolger AP, Doehner W, Rauchhaus M, Davos C, Sharma R, Al-Nasser FO, Coats AJ, Anker SD. High tumour necrosis factoralpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine 15:80-86, 2001. (Pubitemid 34920508)
10. Close RI. Dynamic properties of mammalian skeletal muscles. Physiol Rev 52:129-197, 1972.
11. Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, Bossa F, Angelucci E, Biancone L, Gionchetti P, Ardizzone S, Papi C, Fries W, Danese S, Riegler G, Cappello M, Castiglione F, Annese V, Orlando A. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 9:30-35, 2011.
12. Crecelius AR, Kirby BS, Voyles WF, Dinenno FA. Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults. Am J Physiol Heart Circ Physiol 299:H1633-H1641, 2010.
13. Cunha TM, Souza GR, Domingues AC, Carreira EU, Lotufo CM, Funez MI, Verri WA Jr, Cunha FQ, Ferreira SH. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kgamma/AKT/nNOS/NO signaling pathway. Mol Pain 8:10, 2012.
14. De Simone C, Murri R, Maiorino A, Venier A, Caldarola G. Management of recurrent cutaneous abscesses during therapy with infliximab. Clin Ther 33:1993-1996, 2011.
15. Eringa EC, Stehouwer CD, Walburg K, Clark AD, van Nieuw Amerongen GP, Westerhof N, Sipkema P. Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-alpha dependence on c-Jun. N-terminal kinase. Arterioscler Thromb Vasc Biol 26:274-280, 2006. (Pubitemid 43732187)
16. Ferreira LF, Campbell KS, Reid MB. N-acetylcysteine in handgrip exercise: plasma thiols and adverse reactions. Int J Sport Nutr Exerc Metab 21:146-154, 2011.
17. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 194:7-15, 2011.
18. Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 mo of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124-131, 2011.
19. Gilliam LA, Moylan JS, Ferreira LF, Reid MB. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness. Am J Physiol Lung Cell Mol Physiol 300:L225-L231, 2011.
20. Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T. Implications of cross-talk between tumour necrosis factor and insulinlike growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol 35:846-851, 2008. (Pubitemid 351725233)
21. Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, Reid MB. TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol 104:694-699, 2008. (Pubitemid 351468797)
22. Jackson MJ, McArdle A. Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species. J Physiol 589:2139-2145, 2011.
23. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 45:1-17, 2008.
24. Jubrias SA, Odderson IR, Esselman PC, Conley KE. Decline in isokinetic force with age: muscle cross-sectional area and specific force. Pflugers Arch 434:246-253, 1997. (Pubitemid 27276226)
25. Kellogg DL Jr, Zhao JL, Wu Y. Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. J Physiol 586:847-857, 2008. (Pubitemid 351194122)
26. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 372:546-548, 1994. (Pubitemid 24368535)
27. Kobzik L, Stringer B, Balligand JL, Reid MB, Stamler JS. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 211:375-381, 1995.
28. Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 169:1022-1027, 2004. (Pubitemid 38543641)
29. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70:2446-2453, 1998.
30. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26:587-593, 2002. (Pubitemid 34315867)
31. Ladner KJ, Caligiuri MA, Guttridge DC. Tumor necrosis factorregulated biphasic activation of NF-kappa B is required for cytokineinduced loss of skeletal muscle gene products. J Biol Chem 278:2294-2303, 2003. (Pubitemid 36801299)
32. Lai CF, Shao JS, Behrmann A, Krchma K, Cheng SL, Towler DA. TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. Endocrinology 153:3897-3910, 2012.
33. Langen RC, Schols AM, Kelders MC, Van der Velden JL, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and-independent pathways. Am J Physiol Cell Physiol 283:C714-C721, 2002. (Pubitemid 34920304)
34. Levine S, Nguyen T, Kaiser LR, Rubinstein NA, Maislin G, Gregory C, Rome LC, Dudley GA, Sieck GC, Shrager JB. Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med 168:706-713, 2003. (Pubitemid 37175973)
35. Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102:1690-1696, 2000.
36. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19:362-370, 2005. (Pubitemid 40316524)
37. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17:1048-1057, 2003. (Pubitemid 36676391)
38. Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279:R1165-R1170, 2000.
39. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 12:871-880, 1998. (Pubitemid 28294677)
40. Liaudet L, Vassalli G, Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front Biosci 14:4809-4814, 2009.
41. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R. Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111:1763-1770, 2005. (Pubitemid 40525140)
42. Murrant CL, Andrade FH, Reid MB. Exogenous reactive oxygen and nitric oxide alter intracellular oxidant status of skeletal muscle fibres. Acta Physiol Scand 166:111-121, 1999. (Pubitemid 29304170)
43. Ottenheijm CA, Heunks LM, Sieck GC, Zhan WZ, Jansen SM, Degens H, de Boo T, Dekhuijzen PN. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172:200-205, 2005. (Pubitemid 40981194)
44. Park CS, Park R, Krishna G. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues. Life Sci 59:219-225, 1996. (Pubitemid 26201049)
45. Pérez-Alvarez R, Díaz-Lagares C, García- Hernández F, Lopez-Roses L, Brito-Zerón P, Pérez-de-Lis M, Retamozo S, Bové A, Bosch X, Sanchez-Tapias JM. Forns X, Ramos-Casals M, BIOGEAS Study Group. Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases. Medicine (Baltimore) 90:359-371, 2011.
46. Puente-Maestu L, Tejedor A, Lázaro A, de Miguel J, Alvarez-Sala L, González-Aragoneses F, Simón C, Agustí A. Site of mitochondrial reactive oxygen species production in skeletal muscle of COPD and its relationship with exercise oxidative stress. Am J Respir Cell Mol Biol 47:358-362, 2012.
47. Reid MB, Khawli FA, Moody MR. Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle. J Appl Physiol 75:1081-1087, 1993. (Pubitemid 23289594)
48. Reid MB, Kobzik L, Bredt DS, Stamler JS. Nitric oxide modulates excitation-contraction coupling in the diaphragm. Comp Biochem Physiol A Mol Integr Physiol 119:211-218, 1998. (Pubitemid 28162388)
49. Reid MB, Lannergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166:479-484, 2002.
50. Reid MB, Stokic DS, Koch SM, Khawli FA, Leis AA. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 94:2468-2474, 1994. (Pubitemid 24379623)
51. Sanchez-Blazquez P, Rodriguez-Munoz M, Bailon C, Garzon J. GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein. Antioxid Redox Signal 17:1163-1177, 2012.
52. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183-1189, 2009.
53. Schrage WG, Wilkins BW, Johnson CP, Eisenach JH, Limberg JK, Dietz NM, Curry TB, Joyner MJ. Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans. J Appl Physiol 109:768-777, 2010.
54. Sriram S, Subramanian S, Sathiakumar D, Venkatesh R, Salerno MS, McFarlane CD, Kambadur R, Sharma M. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-kappaB. Aging Cell 10:931-948, 2011.
55. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 81:209-237, 2001. (Pubitemid 32096176)
56. Szabadits E, Cserep C, Szonyi A, Fukazawa Y, Shigemoto R, Watanabe M, Itohara S, Freund TF, Nyiri G. NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling. J Neurosci 31:5893-5904, 2011.
57. Szentesi P, Bekedam MA, van Beek-Harmsen BJ, van der Laarse WJ, Zaremba R, Boonstra A, Visser FC, Stienen GJ. Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure. J Appl Physiol 99:2189-2195, 2005. (Pubitemid 41691637)
58. Szeto HH, Schiller PW. Novel therapies targeting inner mitochondrial membrane-from discovery to clinical development. Pharm Res 28:2669-2679, 2011.
59. Tong D, Manolios N, Howe G, Spencer D. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J 42:89-94, 2012.
60. Vescovo G, Ravara B, Dalla Libera L. Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure. Basic Res Cardiol 103:285-290, 2008.
61. Wilcox P, Milliken C, Bressler B. High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor. Am J Respir Crit Care Med 153:1611-1615, 1996.
62. Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J. Tumor necrosis factor alpha decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med 150:1368-1373, 1994. (Pubitemid 24356654)
63. Williams G, Brown T, Becker L, Prager M, Giroir BP. Cytokineinduced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol Regul Integr Comp Physiol 267:R1020-R1025, 1994.
64. Winkelman C. Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin Issues 15:74-82, 2004.
65. Xie J, Wang Y, Lippton H, Cai B, Nelson S, Kolls J, Summer WR, Greenberg SS. Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide. Am Rev Respir Dis 148:627-636, 1993. (Pubitemid 23263771)
66. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61:10-16, 2006. (Pubitemid 43106971)
67. Zuo L, Nogueira L, Hogan MC. Effect of pulmonary TNF-alpha overexpression on mouse isolated skeletal muscle function. Am J Physiol Regul Integr Comp Physiol 301:R1025-R1031, 2011.